11 – 20 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjögren's syndrome and systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Prasugrel 5 mg inhibits platelet P-selectin and GPIIb–IIIa expression in very elderly and non elderly : results from the GENERATIONS trial, a pharmacodynamic study in stable CAD patients
(
- Contribution to journal › Article
-
Mark
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
(
- Contribution to journal › Article
- 2015
-
Mark
Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Temperature effects on haemostasis in whole blood from ticagrelor- and aspirin-treated patients with acute coronary syndrome.
(
- Contribution to journal › Article
- 2014
-
Mark
Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization.
(
- Contribution to journal › Article
-
Mark
Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.
(
- Contribution to journal › Article
- 2013
-
Mark
Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
(
- Contribution to journal › Article